Educational directory entry
Methotrexate
Direct answer (B2B summary)
Methotrexate (methotrexate): neutral, non-prescriptive summary for B2B sourcing and shortage planning. This entry is written for hospital, clinic, and pharmacy procurement readers in the Oncology / Immunology space. Availability may depend on jurisdiction and regulatory status; requests are quotation-based.
Antimetabolite therapy used in oncology and, in other settings, under distinct protocols and monitoring.
What this medication is commonly used for
Commonly requested where oncology or specialty protocols require methotrexate formulations consistent with local labeling.
This section is informational only. Treatment decisions belong to qualified clinicians and local labeling.
Shortage and sourcing context
Methotrexate shortages have affected tablets and injectable presentations at different times. Substitution decisions are clinical and regulatory.
Who typically requests this medication
- Hospitals and hospital pharmacies managing formulary access
- Clinics and specialty clinics with defined treatment pathways
- Specialty pharmacies serving complex therapies
- Medical procurement teams coordinating licensed sourcing
Availability depends on market conditions and regulatory requirements. This page is informational and does not replace local governance.
Presentation and strength examples
- Dosage forms (examples): Tablet, Injection
- Strengths (examples): 2.5 mg, 25 mg/mL (examples)
- Active ingredient (INN): methotrexate
Request availability for this medication
Submit a procurement inquiry for review against licensed wholesale networks. No guaranteed availability or shipment.
Request availability for this medicationFAQ
Related medications
Related insights
Long-form reference: the sections above summarize procurement-oriented context. For extended narrative content where available, see also the structured description below.
Antimetabolite therapy used in oncology and, in other settings, under distinct protocols and monitoring.
What this medicine is commonly associated with
Commonly requested where oncology or specialty protocols require methotrexate formulations consistent with local labeling.
Shortage and sourcing context
Methotrexate shortages have affected tablets and injectable presentations at different times. Substitution decisions are clinical and regulatory.
Presentation examples
Dosage forms referenced on this page may include: Tablet, Injection. Strength examples may include: 2.5 mg, 25 mg/mL (examples). Actual market presentations vary by region and registration.
Important: This page is informational and not a substitute for professional medical advice, local labeling, or institutional protocols.